. april 2008 (21).in a news release, the drug's manufacturer, amgen, said the list price will be 5 a month or ,900 annually. costs to patients may vary depending on insurance.."the importance of our new method is that it allows for precise and automated measurement of the disease," bentley added in the study published in the journal radiology... taking ustekinumab�a biologic that targets a different aspect of the immune system," gelfand said.